even a rough estimate of the numbers they are getting for cardiocel sales would be reassuring. Alternatively an estimate of % of procedures they are getting. We know they will not be getting 100% of eligible procedures, but it would be good to get an understanding of how they are progressing within the market.
Even if they are only getting 5 procedures a month in a centre, i think that would provide more confidence to wider community. I am abit over hearing what the potential market is. We already know that. The business is about converting to AHZ business.
Interview with Dr Julian Chick, page-19
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.15 |
Change
-0.250(2.40%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| $10.57 | $10.59 | $9.90 | $181.3K | 17.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 720 | $10.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 3407 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |